Literature DB >> 17279751

Synthesis of a ring-expanded bryostatin analogue.

Barry M Trost1, Hanbiao Yang, Oliver R Thiel, Alison J Frontier, Cheyenne S Brindle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17279751      PMCID： PMC2533160          DOI： 10.1021/ja067305j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  20 in total

1.  The practical synthesis of a novel and highly potent analogue of bryostatin.

Authors:  Paul A Wender; Jeremy L Baryza; Chad E Bennett; F Christopher Bi; Stacey E Brenner; Michael O Clarke; Joshua C Horan; Cindy Kan; Emmanuel Lacôte; Blaise Lippa; Peter G Nell; Tim M Turner
Journal:  J Am Chem Soc       Date:  2002-11-20       Impact factor: 15.419

Review 2.  The chemistry and biology of the bryostatin antitumour macrolides.

Authors:  Karl J Hale; Marc G Hummersone; Soraya Manaviazar; Mark Frigerio
Journal:  Nat Prod Rep       Date:  2002-08       Impact factor: 13.423

3.  Synthetic studies toward the bryostatins: a substrate-controlled approach to the A-ring.

Authors:  Gary E Keck; Dennie S Welch; Paige K Vivian
Journal:  Org Lett       Date:  2006-08-17       Impact factor: 6.005

4.  Synthesis and PKC binding of a new class of a-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategy.

Authors:  Paul A Wender; Joshua C Horan
Journal:  Org Lett       Date:  2006-09-28       Impact factor: 6.005

5.  A Ru-catalyzed tandem alkyne-enone coupling/Michael addition: synthesis of 4-methylene-2,6-cis-tetrahydropyrans.

Authors:  Barry M Trost; Hanbiao Yang; Georg Wuitschik
Journal:  Org Lett       Date:  2005-10-13       Impact factor: 6.005

6.  C-15 thiazol-4-yl analogues of (E)-9,10-didehydroepothilone D: synthesis and cytotoxicity.

Authors:  Brian R Hearn; Dan Zhang; Yong Li; David C Myles
Journal:  Org Lett       Date:  2006-07-06       Impact factor: 6.005

7.  Phase I study of bryostatin 1 and gemcitabine.

Authors:  Basil F El-Rayes; Shirish Gadgeel; Anthony F Shields; Stephanie Manza; Patricia Lorusso; Philip A Philip
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

8.  Enantioselective formal total synthesis of the antitumor macrolide bryostatin 7.

Authors:  Soraya Manaviazar; Mark Frigerio; Gurpreet S Bhatia; Marc G Hummersone; Abil E Aliev; Karl J Hale
Journal:  Org Lett       Date:  2006-09-28       Impact factor: 6.005

9.  Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma.

Authors:  Lance C Pagliaro; Cherie A Perez; Shi-Ming Tu; Danai D Daliani
Journal:  Urol Oncol       Date:  2006 Nov-Dec       Impact factor: 3.498

10.  Total synthesis of polycavernoside A, a lethal toxin of the red alga Polycavernosa tsudai.

Authors:  Paul R Blakemore; Cindy C Browder; Jian Hong; Christopher M Lincoln; Pavel A Nagornyy; Lonnie A Robarge; Duncan J Wardrop; James D White
Journal:  J Org Chem       Date:  2005-07-08       Impact factor: 4.354
View more
  19 in total

1.  Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis.

Authors:  Paul A Wender; Brian A Loy; Adam J Schrier
Journal:  Isr J Chem       Date:  2011-03-24       Impact factor: 3.333

2.  Enantioselective synthesis of (-)-exiguolide by iterative stereoselective dioxinone-directed Prins cyclizations.

Authors:  Erika A Crane; Thomas P Zabawa; Rebecca L Farmer; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2011-09-19       Impact factor: 15.336

3.  A new construction of 2-alkoxypyrans by an acylation-reductive cyclization sequence.

Authors:  Lars V Heumann; Gary E Keck
Journal:  Org Lett       Date:  2007-04-12       Impact factor: 6.005

Review 4.  Recent advances in the chemistry and biology of naturally occurring antibiotics.

Authors:  K C Nicolaou; Jason S Chen; David J Edmonds; Anthony A Estrada
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  Total synthesis of bryostatin 16 using a Pd-catalyzed diyne coupling as macrocyclization method and synthesis of C20-epi-bryostatin 7 as a potent anticancer agent.

Authors:  Barry M Trost; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2010-11-02       Impact factor: 15.419

6.  Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy.

Authors:  Paul A Wender; Brian A Dechristopher; Adam J Schrier
Journal:  J Am Chem Soc       Date:  2008-05-02       Impact factor: 15.419

7.  Synthesis and Biological Evaluation of Fluorescent Bryostatin Analogues.

Authors:  Thomas J Cummins; Noemi Kedei; Agnes Czikora; Nancy E Lewin; Sharon Kirk; Mark E Petersen; Kevin M McGowan; Jin-Qiu Chen; Xiaoling Luo; Randall C Johnson; Sarangan Ravichandran; Peter M Blumberg; Gary E Keck
Journal:  Chembiochem       Date:  2018-03-25       Impact factor: 3.164

Review 8.  Transition metal-catalyzed couplings of alkynes to 1,3-enynes: modern methods and synthetic applications.

Authors:  Barry M Trost; James T Masters
Journal:  Chem Soc Rev       Date:  2016-02-01       Impact factor: 54.564

9.  Allylmalonate as an activator subunit for the initiation of relay ring-closing metathesis reactions.

Authors:  Thomas R Hoye; Junha Jeon; Manomi A Tennakoon
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-21       Impact factor: 15.336

10.  Evaluation of Chromane-Based Bryostatin Analogues Prepared via Hydrogen-Mediated C-C Bond Formation: Potency Does Not Confer Bryostatin-like Biology.

Authors:  John M Ketcham; Ivan Volchkov; Te-Yu Chen; Peter M Blumberg; Noemi Kedei; Nancy E Lewin; Michael J Krische
Journal:  J Am Chem Soc       Date:  2016-09-27       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.